- Home
- CYTK vs WSC Comparison
CYTK vs WSC Comparison
Compare CYTK & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- WSC
- Stock Information
- Founded
- CYTK 1997
- WSC 1944
- Country
- CYTK United States
- WSC United States
- Employees
- CYTK N/A
- WSC N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- WSC Misc Corporate Leasing Services
- Sector
- CYTK Health Care
- WSC Industrials
- Exchange
- CYTK Nasdaq
- WSC Nasdaq
- Market Cap
- CYTK 4.6B
- WSC 5.3B
- IPO Year
- CYTK 2004
- WSC N/A
- Fundamental
- Price
- CYTK $53.01
- WSC $23.71
- Analyst Decision
- CYTK Buy
- WSC Buy
- Analyst Count
- CYTK 15
- WSC 7
- Target Price
- CYTK $75.57
- WSC $36.00
- AVG Volume (30 Days)
- CYTK 2.6M
- WSC 2.1M
- Earning Date
- CYTK 11-05-2025
- WSC 10-29-2025
- Dividend Yield
- CYTK N/A
- WSC 1.19%
- EPS Growth
- CYTK N/A
- WSC N/A
- EPS
- CYTK N/A
- WSC 0.59
- Revenue
- CYTK $85,738,000.00
- WSC $2,352,581,000.00
- Revenue This Year
- CYTK $330.96
- WSC N/A
- Revenue Next Year
- CYTK $73.41
- WSC $3.15
- P/E Ratio
- CYTK N/A
- WSC $40.27
- Revenue Growth
- CYTK 2635.74
- WSC N/A
- 52 Week Low
- CYTK $29.31
- WSC $21.91
- 52 Week High
- CYTK $59.39
- WSC $42.15
- Technical
- Relative Strength Index (RSI)
- CYTK 77.96
- WSC 38.71
- Support Level
- CYTK $35.22
- WSC $22.86
- Resistance Level
- CYTK $50.22
- WSC $25.08
- Average True Range (ATR)
- CYTK 2.29
- WSC 0.73
- MACD
- CYTK 1.64
- WSC 0.07
- Stochastic Oscillator
- CYTK 94.73
- WSC 36.64
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.